z-logo
Premium
Antibody–Prodrug Conjugates with KSP Inhibitors and Legumain‐Mediated Metabolite Formation
Author(s) -
Lerchen HansGeorg,
StelteLudwig Beatrix,
Berndt Sandra,
Sommer Anette,
Dietz Lisa,
Rebstock AnneSophie,
Johannes Sarah,
Marx Leo,
Jörißen Hannah,
Mahlert Christoph,
Greven Simone
Publication year - 2019
Publication title -
chemistry – a european journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.687
H-Index - 242
eISSN - 1521-3765
pISSN - 0947-6539
DOI - 10.1002/chem.201901770
Subject(s) - prodrug , conjugate , cleavage (geology) , lysosome , chemistry , metabolite , peptide , biochemistry , stereochemistry , computer science , combinatorial chemistry , computational biology , enzyme , biology , mathematics , mathematical analysis , fracture (geology) , paleontology
Invited for the cover of this issue is the group of Hans‐Georg Lerchen and colleagues from Bayer AG R&D Pharmaceuticals. The image, provided by J. Franz and graphic designers from The New Atlantic (Cologne), depicts a cartoon representation of the legumain‐mediated cleavage of the peptide cap within the lysosome. Read the full text of the article at 10.1002/chem.201900441.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom